Phase I Dose-Finding Study of Eribulin and Capecitabine for Metastatic Breast Cancer: JBCRG-18 Cape Study
Breast Cancer - Japan
doi 10.1007/s12282-017-0798-4
Full Text
Open PDFAbstract
Available in full text
Date
August 31, 2017
Authors
Publisher
Springer Science and Business Media LLC